{"name": "Inimex Pharmaceuticals",
 "permalink": "inimex-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/inimex-pharmaceuticals",
 "homepage_url": "http://www.inimexpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@inimexpharma.com",
 "phone_number": "(604) 225-2251",
 "description": "Innate Defense Regulators",
 "created_at": "Thu Jun 04 10:03:23 UTC 2009",
 "updated_at": "Mon Aug 24 21:54:27 UTC 2009",
 "overview": "\u003Cp\u003EInimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body\u0026#8217;s innate defenses without causing inflammation.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[125,
       46],
      "assets/images/resized/0004/6632/46632v1-max-150x150.jpg"],
     [[125,
       46],
      "assets/images/resized/0004/6632/46632v1-max-250x250.jpg"],
     [[125,
       46],
      "assets/images/resized/0004/6632/46632v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "John",
      "last_name": "R. North",
      "permalink": "john-r-north",
      "image":
       {"available_sizes":
         [[[75,
            90],
           "assets/images/resized/0004/6633/46633v1-max-150x150.jpg"],
          [[75,
            90],
           "assets/images/resized/0004/6633/46633v1-max-250x250.jpg"],
          [[75,
            90],
           "assets/images/resized/0004/6633/46633v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Martin",
      "last_name": "(Marty) McConnell",
      "permalink": "martin-marty-mcconnell",
      "image":
       {"available_sizes":
         [[[80,
            79],
           "assets/images/resized/0004/6636/46636v1-max-150x150.jpg"],
          [[80,
            79],
           "assets/images/resized/0004/6636/46636v1-max-250x250.jpg"],
          [[80,
            79],
           "assets/images/resized/0004/6636/46636v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Director",
    "person":
     {"first_name": "Oreola",
      "last_name": "Donini",
      "permalink": "oreola-donini",
      "image":
       {"available_sizes":
         [[[75,
            90],
           "assets/images/resized/0004/6635/46635v1-max-150x150.jpg"],
          [[75,
            90],
           "assets/images/resized/0004/6635/46635v1-max-250x250.jpg"],
          [[75,
            90],
           "assets/images/resized/0004/6635/46635v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$26.5M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 22000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 6,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Canadian Medical Discoveries Fund",
         "permalink": "canadian-medical-discoveries-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Astellas Venture Management",
         "permalink": "astellas-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6637/46637v3-max-150x150.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-250x250.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Morningside Group",
         "permalink": "morningside-group",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0002/9760/29760v1-max-150x150.png"],
             [[238,
               41],
              "assets/images/resized/0002/9760/29760v1-max-250x250.png"],
             [[238,
               41],
              "assets/images/resized/0002/9760/29760v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Roche Venture Fund",
         "permalink": "roche-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BC Advantage Funds",
         "permalink": "b-c-advantage-funds",
         "image":
          {"available_sizes":
            [[[150,
               80],
              "assets/images/resized/0004/4160/44160v2-max-150x150.png"],
             [[164,
               88],
              "assets/images/resized/0004/4160/44160v2-max-250x250.png"],
             [[164,
               88],
              "assets/images/resized/0004/4160/44160v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Discovery Capital",
         "permalink": "discovery-capital",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0002/3230/23230v1-max-150x150.png"],
             [[210,
               78],
              "assets/images/resized/0002/3230/23230v1-max-250x250.png"],
             [[210,
               78],
              "assets/images/resized/0002/3230/23230v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BDC Venture Capital",
         "permalink": "bdc-venture-capital-2",
         "image":
          {"available_sizes":
            [[[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-150x150.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-250x250.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GrowthWorks Capital",
         "permalink": "growthworks",
         "image":
          {"available_sizes":
            [[[150,
               38],
              "assets/images/resized/0002/8728/28728v1-max-150x150.png"],
             [[187,
               48],
              "assets/images/resized/0002/8728/28728v1-max-250x250.png"],
             [[187,
               48],
              "assets/images/resized/0002/8728/28728v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.inimexpharma.com/docs/news-releases/2004/PR20040706.pdf",
    "source_description": "Inimex Pharmaceuticals Announces $2 Million Second Closing of Series A ",
    "raised_amount": 4500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2004,
    "funded_month": 7,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BDC Venture Capital",
         "permalink": "bdc-venture-capital-2",
         "image":
          {"available_sizes":
            [[[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-150x150.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-250x250.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canadian Medical Discoveries Fund",
         "permalink": "canadian-medical-discoveries-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GrowthWorks Capital",
         "permalink": "growthworks",
         "image":
          {"available_sizes":
            [[[150,
               38],
              "assets/images/resized/0002/8728/28728v1-max-150x150.png"],
             [[187,
               48],
              "assets/images/resized/0002/8728/28728v1-max-250x250.png"],
             [[187,
               48],
              "assets/images/resized/0002/8728/28728v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8540 Baxter Place ",
    "address2": "",
    "zip_code": "V5A 4T8",
    "city": "Burnaby, B.C. ",
    "state_code": null,
    "country_code": "CAN",
    "latitude": 49.2589767,
    "longitude": -122.9150026}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0004/6631/46631v1-max-150x150.jpg"],
      [[250,
        133],
       "assets/images/resized/0004/6631/46631v1-max-250x250.jpg"],
      [[450,
        239],
       "assets/images/resized/0004/6631/46631v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}